Keywords: Tumors (Pre-Treatment), Brain
Motivation: Preoperative glioma classification and management is still a challenge to be solved.
Goal(s): To enhance the understanding of glioma characteristics and potentially improve patient outcomes, we analyzed 7T Magnetic Resonance Spectroscopic Imaging (MRSI) data in 36 glioma patients.
Approach: Our approach focused on k-Means clustering of 60 metabolic ratios in the tumor to identify an overlap with the WHO 2021 diagnosis. Important metabolic ratios identified include Glu+Gln/tCho and Ins/tCr ratios, highlighting their biomarker significance.
Results: Our 7T MRSI can add metabolic profiles across the entire glioma and brain, possibly contributing to future glioma research.
Impact: We performed k-Means clustering of preoperative 7T MRSI metabolic ratios in 36 glioma patients. Correlation with histological WHO 2021 diagnosis was identified. With this approach, we could potentially enhance surgery planning and optimize glioma treatment and targeted drug monitoring.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords